BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23009609)

  • 21. Zoledronic acid prevents cancer treatment-induced bone loss.
    Oncology (Williston Park); 2005 Mar; 19(3):390. PubMed ID: 15828553
    [No Abstract]   [Full Text] [Related]  

  • 22. Inappropriate ATAC on tamoxifen.
    Ucci G
    Lancet Oncol; 2008 Apr; 9(4):314-5. PubMed ID: 18374286
    [No Abstract]   [Full Text] [Related]  

  • 23. [Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].
    Aumiller J
    MMW Fortschr Med; 2005 Mar; 147(10):4-6. PubMed ID: 15803773
    [No Abstract]   [Full Text] [Related]  

  • 24. Aromatase inhibitors for the treatment and prevention of breast cancer.
    Kalidas M; Brown P
    Clin Breast Cancer; 2005 Apr; 6(1):27-37. PubMed ID: 15899070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.
    Aihara T; Takatsuka Y; Ohsumi S; Aogi K; Hozumi Y; Imoto S; Mukai H; Iwata H; Watanabe T; Shimizu C; Nakagami K; Tamura M; Ito T; Masuda N; Ogino N; Hisamatsu K; Mitsuyama S; Abe H; Tanaka S; Yamaguchi T; Ohashi Y
    Breast Cancer Res Treat; 2010 Jun; 121(2):379-87. PubMed ID: 20390343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
    Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on adjuvant hormonal treatment of early breast cancer.
    Lao Romera J; Puertolas Hernández TJ; Peláez Fernández I; Sampedro Gimeno T; Fernández Martínez R; Fernández Pérez I; Iranzo González Cruz V; Illarramendi Mañas JJ; Garcerá Juan S; Ciruelos Gil EM
    Adv Ther; 2011 Sep; 28 Suppl 6():1-18. PubMed ID: 21922392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
    Gradishar WJ
    Oncology; 2005; 69(1):1-9. PubMed ID: 16088229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
    J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
    Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
    Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy concept: herceptin in combination with arimidex].
    von Minckwitz G
    Onkologie; 2002 Dec; 25 Suppl 5():22 ; discussion 22-4. PubMed ID: 23573617
    [No Abstract]   [Full Text] [Related]  

  • 34. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended adjuvant therapy with letrozole: reducing the risk of recurrence.
    Dixon JM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):849-59. PubMed ID: 16761928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
    Bock VL; Friedlander M; Waring D; Kossard S; Wood GK
    Australas J Dermatol; 2014 Nov; 55(4):282-5. PubMed ID: 24575835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer prevention.
    Thornton H
    Br J Gen Pract; 2003 Feb; 53(487):150. PubMed ID: 12817365
    [No Abstract]   [Full Text] [Related]  

  • 38. Update: a 62-year-old woman with a new diagnosis of breast cancer.
    Farag N; Burns R; Come SE
    JAMA; 2008 Mar; 299(9):1055-6. PubMed ID: 18319415
    [No Abstract]   [Full Text] [Related]  

  • 39. Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment.
    Işçi H; Güdücü N; Basgul AY; Aydinli K; Calay Z; Dünder I
    Eur J Gynaecol Oncol; 2011; 32(5):560-2. PubMed ID: 22053676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin.
    Carlini P; Di Cosimo S; Ferretti G; Papaldo P; Fabi A; Ruggeri EM; Milella M; Cognetti F
    Ann Oncol; 2003 Nov; 14(11):1689-90. PubMed ID: 14581280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.